Weihua Yang

机构：Southern Medical University Shenzhen Hospital · ORCID：0000-0001-5468-758X

发表论文 62 篇 · 总被引 2122 次 · h-index 14

代表论文

• Sensitivity evaluation of 2019 novel coronavirus (SARS-CoV-2) RT-PCR detection kits and strategy to reduce false negative (2020 · PLoS ONE · 被引 64)
• Neoadjuvant SHR-1701 with or without chemotherapy in unresectable stage III non-small-cell lung cancer: A proof-of-concept, phase 2 trial (2024 · Cancer Cell · 被引 59)
• Garsorasib in patients with KRASG12C-mutated non-small-cell lung cancer in China: an open-label, multicentre, single-arm, phase 2 trial (2024 · The Lancet Respiratory Medicine · 被引 42)
• Iruplinalkib (WX-0593) Versus Crizotinib in ALK TKI-Naive Locally Advanced or Metastatic ALK-Positive NSCLC: Interim Analysis of a Randomized, Open-Label, Phase 3 Study (INSPIRE) (2024 · Journal of Thoracic Oncology · 被引 40)
• Efficacy and safety of iruplinalkib (WX-0593) in ALK-positive crizotinib-resistant advanced non-small cell lung cancer patients: a single-arm, multicenter phase II study (INTELLECT) (2023 · BMC Medicine · 被引 24)
• Recurrence of moderate to severe ulcerative colitis after fecal microbiota transplantation treatment and the efficacy of re-FMT: a case series (2020 · BMC Gastroenterology · 被引 16)